Nanofibres are extremely thin fibers, typically less than 100 nanometers in diameter, made from various materials such as polymers, carbon, or metals. They work by providing a scaffold for cells to grow and form tissues, allowing for the regeneration of damaged tissues in the body.
Samuel Stupp is using nanofibres to create a scaffold that mimics the structure of native tissues, such as nerve or muscle tissue. This scaffold can be implanted into damaged areas, promoting the growth of new cells and ultimately restoring mobility.
Nanofibre technology has the potential to treat a wide range of injuries and conditions, including spinal cord injuries, muscle and nerve damage, bone fractures, and cartilage defects. It can also be used in regenerative medicine to replace damaged or diseased tissues and organs.
While nanofibre technology is still in its early stages, there are currently no known serious risks or side effects associated with its use. However, as with any medical treatment, there may be some minor risks, and more research is needed to fully understand the long-term effects.
Nanofibre technology is already being used in some clinical trials, and it is expected to become more widely available in the near future. However, it may still be several years before it is approved for use in mainstream medical treatments and becomes a standard option for restoring mobility.